Democrats outline congressional probes of Trump business deals
Reuters reports that incoming Democratic committee leaders are planning investigations and drug-pricing scrutiny.

The brief
- ■Democrats won control of the House and Senate, Reuters reports
- ■Incoming committee leaders are outlining an oversight agenda
- ■The White House denies wrongdoing and criticizes the proposed investigations
Why it matters
The next Congress’s oversight agenda could bring new scrutiny to federal decisions that affect American households.
Following the midterm elections, Democratic lawmakers outlined plans to use congressional investigative powers to examine Trump family business dealings and administration actions, according to Reuters.
Senator Ron Wyden also said he plans to scrutinize administration agreements with pharmaceutical companies on drug pricing. These are proposed investigations, not findings of wrongdoing; the administration denies wrongdoing and has criticized the plans.
Sources
- Reuters via StreetInsider — November 5, 2026, 6:09 a.m. EST
More briefs

Breaking · Politics
Democrats sweep the midterms and take both chambers of Congress
6h ago · 1 min brief

Politics
Vance blames the Iran war for the Republican wipeout
8h ago · 1 min brief

Culture
Pixar names Jonathan Garson president in January leadership change
3h ago · 1 min brief
